Khoza-Shangase Katijah
Audiology Department, School of Human & Community Development, Faculty of Humanities, University of the Witwatersrand, Johannesburg 2050, South Africa.
Int J Environ Res Public Health. 2025 Mar 25;22(4):487. doi: 10.3390/ijerph22040487.
Hearing loss remains a significant but underexplored health challenge in individuals with HIV/AIDS, particularly those exposed to occupational noise. The ototoxic effects of antiretroviral therapy (ART) and comorbid conditions like tuberculosis (TB) further compound the risk. This narrative review examines the intersection of HIV/AIDS, ART, and occupational noise-induced hearing loss (ONIHL), emphasizing the South African and broader African contexts. The aim of the study was to map the existing literature on the association between HIV/AIDS, its treatments, and ONIHL, and to identify research gaps to inform policy and clinical practice. A narrative review approach was adopted, systematically searching databases including PubMed, Scopus, and Web of Science. Studies published between 2000 and 2024 were included, focusing on the effects of HIV/AIDS, ART, and occupational noise exposure on hearing health. Data extraction and thematic synthesis were performed to identify key findings and gaps. Twenty studies were included, covering diverse settings such as South Africa, Cameroon, Tanzania, and the USA. Three key themes emerged: (1) dual burden of HIV and occupational noise exposure: HIV-positive individuals in noise-intensive industries, such as mining, face amplified risks of hearing loss due to immunological compromise and ototoxic TB treatments; (2) ototoxicity of ART: older ART regimens, widely used in resource-limited settings, are associated with a higher prevalence of sensorineural hearing loss (SNHL); and (3) immunological susceptibility to ONIHL: HIV-related immune suppression exacerbates cochlear damage from noise and ototoxic agents, contributing to both peripheral and central auditory dysfunction. This review highlights the urgent need for integrated hearing health interventions in HIV care and occupational health frameworks, particularly in high-prevalence regions like South Africa. Routine audiological assessments, access to safer ART regimens, and enhanced workplace protections are essential to mitigate the dual burden of HIV/AIDS and ONIHL. Future research should prioritize longitudinal studies and innovative, low-cost solutions for resource-limited settings.
听力损失在感染艾滋病毒/艾滋病的个体中仍然是一个重大但未得到充分研究的健康挑战,尤其是那些暴露于职业噪声中的人。抗逆转录病毒疗法(ART)的耳毒性作用以及结核病(TB)等合并症进一步增加了风险。这篇叙述性综述探讨了艾滋病毒/艾滋病、抗逆转录病毒疗法和职业性噪声性听力损失(ONIHL)之间的交叉点,重点关注南非和更广泛的非洲背景。该研究的目的是梳理关于艾滋病毒/艾滋病及其治疗与职业性噪声性听力损失之间关联的现有文献,并确定研究空白,以为政策制定和临床实践提供参考。采用叙述性综述方法,系统检索包括PubMed、Scopus和科学网在内的数据库。纳入了2000年至2〇24年发表的研究,重点关注艾滋病毒/艾滋病、抗逆转录病毒疗法和职业噪声暴露对听力健康的影响。进行了数据提取和主题综合分析,以确定关键发现和空白。纳入了20项研究,涵盖了南非、喀麦隆、坦桑尼亚和美国等不同地区。出现了三个关键主题:(1)艾滋病毒和职业噪声暴露的双重负担:在采矿业等噪声密集型行业中,艾滋病毒呈阳性的个体由于免疫功能受损和耳毒性结核病治疗,面临听力损失风险增加;(2)抗逆转录病毒疗法的耳毒性:在资源有限环境中广泛使用的较旧抗逆转录病毒疗法方案与感音神经性听力损失(SNHL)的较高患病率相关;(3)对职业性噪声性听力损失的免疫易感性:与艾滋病毒相关的免疫抑制会加剧噪声和耳毒性药物对耳蜗的损害,导致外周和中枢听觉功能障碍。本综述强调在艾滋病毒护理和职业健康框架中迫切需要综合听力健康干预措施,特别是在南非等高流行地区。常规听力评估、获得更安全的抗逆转录病毒疗法方案以及加强工作场所保护对于减轻艾滋病毒/艾滋病和职业性噪声性听力损失的双重负担至关重要。未来的研究应优先开展纵向研究,并为资源有限的环境开发创新的低成本解决方案。